Revenue, last year
$18.6M
−8.7% vs prior year
Net income
$3.1M
+295.1% vs prior year
EPS, diluted
$0.04
+300% vs prior year
Operating cash flow
$34.8K
+102% vs prior year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY22 | $18.6M | $3.1M |
| FY21 | $20.4M | −$1.6M |
| FY20 | $21.4M | −$1.4M |
| FY19 | $22.9M | −$3.3M |
| FY18 | $26.3M | $4M |
| FY17 | $26.4M | $699.7K |
| FY16 | $25.7M | $3M |
| FY15 | $1.7M | −$801.5K |
| FY14 | $941.1K | −$1.4M |
| FY13 | $1.1M | $435.4K |
| FY12 | - | −$101.6K |
| FY11 | - | −$122.3K |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY22 | 61.9% | −4.4% | 16.6% |
| FY21 | 58.5% | −10.8% | −7.8% |
| FY20 | 59.4% | −4.8% | −6.7% |
| FY19 | 48.6% | −19% | −14.5% |
| FY18 | 49.3% | −7.4% | 15% |
| FY17 | 44.8% | 3.3% | 2.6% |
| FY16 | 56.1% | 12.3% | 11.8% |
| FY15 | 60.4% | −47.4% | −47.8% |
| FY14 | 48.4% | −141.8% | −149.3% |
| FY13 | 80.8% | 41.2% | 41.1% |
| FY12 | - | - | - |
| FY11 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY22 | - |
| FY21 | - |
| FY20 | $215.9K |
| FY19 | −$20.1K |
| FY18 | $2.4M |
| FY17 | $1.6M |
| FY16 | - |
| FY15 | −$383.4K |
| FY14 | −$1.2M |
| FY13 | $317.9K |
| FY12 | - |
| FY11 | - |
- Fuse Medical
- Consumer median
Show the numbers
| Year | Fuse Medical | Consumer median |
|---|---|---|
| FY22 | 16.6% | 2.5% |
| FY21 | −7.8% | 2.5% |
| FY20 | −6.7% | 1.8% |
| FY19 | −14.5% | 2.6% |
| FY18 | 15% | 3.8% |
| FY17 | 2.6% | 3.8% |
| FY16 | 11.8% | 4.3% |
| FY15 | −47.8% | 3.8% |
| FY14 | −149.3% | 3.6% |
| FY13 | 41.1% | 3.9% |
| FY12 | - | 4.1% |
| FY11 | - | 2.9% |